"id:ID","uuid","description","name","label","id","instanceType","text"
"758","54aec9cf-3d47-44a2-b6d9-66fc86de4bd7","Main objective","OBJ1","","Objective_1","OBJECTIVE","To determine if there is a statistically significant relationship (overall Type 1 erroralpha=0.05) between the change in both the ADAS-Cog (11) and CIBIC+ scores, and drug dose (0, 50 cm2 [54 mg], and 75 cm2 [81 mg])."
"759","47bf8875-02db-48bc-9e38-481e8aeb3625","Safety","OBJ2","","Objective_2","OBJECTIVE","To document the safety profile of the xanomeline TTS."
"760","6abd4a3d-b0df-43c3-92a7-265be99a97b5","Behaviour","OBJ3","","Objective_3","OBJECTIVE","To assess the dose-dependent improvement in behavior. Improved scores on the Revised Neuropsychiatric Inventory (NPI-X) will indicate improvement in these
areas."
